ArticleInternational journal of technology assessment in health care2024

Results of health technology assessments of orphan drugs in Germany-lack of added benefit, evidence gaps, and persisting unmet medical needs.

Philip Kranz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.